baber/WOPTO huggingface dataset:
Patent DK-1257259-T3 (DK)
Inventor: BARBE CHRISTOPHE JEAN ALEXANDRE
IPC: A61K9/52
Filed: 2001-02-21
Granted: 2010-11-01
Abstract: Controlled release ceramic particles, processes for their preparation, controlled release ceramic particles prepared by such processes, compositions comprising such controlled release ceramic particles and methods of using controlled release ceramic particles are described. In one form each of the controlled release ceramic particles has an active material(s) substantially homogeneously dispersed throughout the particles, wherein the active material(s) is capable of being released from said particles, and the active material(s) in said particles is substantially protected from degradation until release of the active material(s) from the particles.
Patent DK-1340392-T3 (DK)
Inventor: VAEAENAENEN KAI
IPC: H04Q7/24
Filed: 2001-10-02
Granted: 2008-09-01
Abstract: The invention relates to a telecommunications system comprising at least a terminal (11) from which a connection can be set up to the Internet (12); and an exchange (14) for routing calls on the basis of information in a register (16). The system further comprises an Internet server (13) comprising means for controlling the installment of the software required in the terminal (11) for making and receiving VoIP calls and the activation of the application required for making and receiving VoIP calls as a response to the request transmitted from the terminal (11); means for changing call forwarding information in the register (16); means for converting the data flow transmitted from the exchange (14) to the terminal (11) into a mode suitable for the terminal (11).
Patent DK-1335996-T3 (DK)
Inventor: OLDANI DARIO
IPC: C25B15/00
Filed: 2001-10-30
Granted: 2011-06-27
Abstract: The invention is relative to an electrolytic cell comprising electrodes spaced apart from the back-wall by means of ribs, wherein a portion of the contact surface between the electrodes and the ribs is free from constraints in order to permit the complete removal of the electrodes once they have to be replaced by removing only partially the original contact surface, so that positioning of the substitute electrodes is allowed on the residual portion. A method for substituting the electrodes of the cell which leaves the distance between the electrode surface and the back-wall unvaried is also disclosed.
Patent DK-1341811-T3 (DK)
Inventor: PRYME IAN
IPC: A61P43/00
Filed: 2001-11-12
Granted: 2008-06-30
Abstract: An orally ingestible preparation consisting essentially of Mistletoe lectin I (ML-I), Mistletoe lectin II (ML-II), and Mistletoe lectin III (ML-III), which specifically excludes the nausea-inducing compounds present in mistletoe extracts. The invention also provides for a method of producing said preparation, a method of using said preparation to produce pharmaceutical preparations, and a method for using said preparation in the treatment of patients suffering from cancer and auto immune diseases.
Patent DK-1266843-T3 (DK)
Inventor: KLOSE GERD-RUEDIGER DR-ING
IPC: B65D85/46
Filed: 2002-05-10
Granted: 2006-05-22
Abstract: The packaged insulation boards (2), of mineral fibers and especially rock wool, are stacked in two overlaid layers and are wrapped in a protective film (8). For transport, the wrapped boards are laid on support bodies (12) by their narrow sides, at right angles to the longitudinal line of the boards. The supports are tied (14) to the wrapped board packages.
Patent DK-1436397-T3 (DK)
Inventor: EMINI EMILIO A
IPC: A61K35/76
Filed: 2002-10-10
Granted: 2010-08-09
Abstract: The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region. The nucleic acid is particularly useful as a component of an adenovector or DNA plasmid vaccine providing a broad range of antigens for generating an HCV specific cell mediated immune (CMI) response against HCV.
Patent DK-1454138-T3 (DK)
Inventor: GILLIES STEPHEN D
IPC: C07K16/24
Filed: 2002-12-04
Granted: 2012-02-13
Abstract: The invention relates to IL-2 fusion protein with improved therapeutic characteristics, especially with reduced toxicity and / or immunogenicity by modification of the amino acid sequence of the IL-2 moiety.
Patent DK-1562731-T3 (DK)
Inventor: LUPKE MANFRED ARNO ALFRED
IPC: B29C48/09
Filed: 2003-11-12
Granted: 2007-09-17
Abstract: An extruding apparatus which extrudes continuous length of hollow plastic product has an extruder ( 3 ) which feeds molten plastic through die equipment ( 5 ) to a mold tunnel ( 7 ) formed by side by side moving mold blocks ( 9 ). The apparatus includes air turbulence internally of the product within the mold tunnel to assist in setting shape of the product. The air turbulence is provided by an air moving member ( 17 ) located internally of the product within the mold tunnel and a power source for the air moving member. The power source is located externally of the mold tunnel and a power transfer is provided to feed power from the power source through the die equipment to the air moving member without cooling of the die equipment.
Patent DK-1601565-T3 (DK)
Inventor: KLEIN ECKHARD
IPC: B62B5/00
Filed: 2004-03-05
Granted: 2008-03-25
Abstract: The lifting device has a track roller It has only one track roller, and can be fixed to the outside of goods in any statically balanced manner. It comprises a rail (1), a vertically movable load carrier, a track roller (13) on the inside of the rail and a clamping arm (7) on the rail. It is fixed to the goods by gripping the bars, legs etc. or by clamping the clamping arm.
Patent DK-1799692-T3 (DK)
Inventor: NISTRI DANIELE
IPC: C07F5/05
Filed: 2004-09-10
Granted: 2009-04-20
Abstract: The present invention relates to metal-phthalocyanines bearing at least a group containing boron isotopes 11B or 10B, covalently bound to the axial positions of metal-phthalocyanine nucleus; moreover it refers to the process for their preparation, the pharmaceutical compositions comprising them and their use for the treatment of neoplastic and dysplastic pathologies in PDT and/or BNCT.
Patent DK-1771732-T3 (DK)
Inventor: SALAMONE SALVATORE
IPC: A61K31/337
Filed: 2005-07-28
Granted: 2010-11-15
Abstract: Novel conjugates of taxol and novel immunogens derived from the 9 and 7 positions of taxol and monoclonal antibodies generated by these taxol linked immunogens are useful in immunoassays for the quantification and monitoring of taxol in biological fluids.
Patent DK-1829545-T3 (DK)
Inventor: KIMURA AKIO
IPC: A61K9/00
Filed: 2005-12-26
Granted: 2012-07-23
Abstract: The present invention provides a resin container in which an aqueous liquid preparation containing a prostaglandin F2± derivative having at least a fluorine atom in its molecule can be stored stably for a long period of time. By storing the aqueous liquid preparation containing the prostaglandin F2± derivative having at least a fluorine atom in its molecule in the resin container made of a propylene/ ethylene copolymer in which the ratio of a propylene component to an ethylene component is in the range of from 94.0/6.0 to 99.5/0.5 (propylene component/ethylene component), a decrease in the content of the prostaglandin F2± derivative in the aqueous liquid preparation is inhibited.
Patent DK-1780269-T3 (DK)
Inventor: WEGGEMAN MIRANDA
IPC: C12N7/00
Filed: 2005-02-21
Granted: 2009-10-12
Abstract: The invention provides a method for removing free adenovirus proteins from a recombinant adenovirus preparation, comprising the step of: subjecting a recombinant adenovirus preparation comprising free adenovirus proteins to a charged filter that contains anion exchange groups.
Patent DK-1989222-T3 (DK)
Inventor: NAKAO YOSHIHIRO
IPC: A23L7/20
Filed: 2007-01-15
Granted: 2012-07-09
Abstract: The present invention relates to a gene encoding a protein responsible for flocculation property of yeast and use thereof, in particular, a brewery yeast with appropriate flocculation property for producing desired alcoholic beverages, alcoholic beverages produced with said yeast, and a method for producing said beverages. More particularly, the present invention relates to a yeast to which suitable flocculation property for brewing desired alcoholic beverages was imparted by controlling expression level of CIS3 gene encoding a protein responsible for flocculation property of brewery yeast, especially non-ScCIS3 gene specific to a lager brewing yeast, to alcoholic beverages produced with said yeast and to a method for producing said beverages.
Patent DK-2021478-T3 (DK)
Inventor: DAMUDE HOWARD GLENN
IPC: A23L19/00
Filed: 2007-05-16
Granted: 2012-05-29
Abstract: Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding delta-5 desaturase along with a method of making long chain polyunsaturated fatty acids (PUFAs) using this delta-5 desaturase in plants and oleaginous yeast are disclosed.
Patent DK-2039521-T3 (DK)
Inventor: HATTORI SHINGO
IPC: B41J2/175
Filed: 2008-02-28
Granted: 2010-04-19
Abstract: An ink cartridge includes a case including a front face and a rear face opposite the front face, an ink supply portion positioned at the front face of the case, an air intake portion positioned at the case, and a movable member configured to move between a first position and a second position relative to the case. The ink cartridge also includes a resilient member having a first end which is coupled to the front face of the case and a second end which is coupled to the movable member. Moreover, the resilient member is configured to expand and to contract to move the movable member relative to the case between the first position and the second position.
Patent DK-2132228-T3 (DK)
Inventor: SIMON SANDY ALEXANDER
IPC: A61K39/395
Filed: 2009-04-11
Granted: 2011-10-10
Abstract: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B-cell related autoimmune, inflammatory, or hyperproliferative diseases.
Patent DK-2271299-T3 (DK)
Inventor: GALPERINE TATIANA
IPC: A61J1/20
Filed: 2009-04-17
Granted: 2012-01-23
Abstract: The invention provides a device (10) for conserving and extemporaneously preparing at least one active principle prior to administration, the device comprising: a body (12) that is constituted by at least one compartment for containing at least one volume of pharmaceutical solvent (22) that is less than 5 mL; a head (14) constituted by at least one compartment for containing at least one active principle (24), in particular a very small dose, and, in its top portion, by at least one dose-taking chamber (32) provided with a filter (40), the head (14) being capable of taking up a first position P1 for conservation, in which said head (14) is in its distal position relative to the body (12), and a second position P2 for preparation, in which said head (14) is in its proximal position relative to the body (12); at least one wall (16) separating the body (12) and the head (14); and rupture means (18) for rupturing said wall (16) so that the active principle (24) enters into contact with the solvent (22) and dissolves therein. The invention also seeks to use the device for conserving and extemporaneously preparing at least one active principle with a view to administering it.
Patent DK-2833905-T3 (DK)
Inventor: MANEVAL DANIEL C
IPC: C12N9/26
Filed: 2013-03-15
Granted: 2018-07-30
Abstract: Provided herein is combination therapy containing an anti-hyaluronan agent, such as a polymer-conjugated hyaluronan-degrading enzyme, and a tumor-targeted taxane, and optionally a further chemotherapeutic agent such as a nucleoside analog. The combination therapy can be used in methods of treating cancers, and in particular solid tumor cancers.
Patent DK-0412464-T3 (DK)
Inventor: FRANCO CHRISTOPHER MILTON MATH
IPC: C12R1/465
Filed: 1990-08-04
Granted: 1992-12-07
Abstract: Butalactin, a compound of the formula I <CHEM> can be produced by cultivation of Streptomyces species Y-86,36923. Butalactin has an antibiotic activity.
Patent DK-0538711-T3 (DK)
Inventor: HEINDL FRIEDRICH
IPC: B29C31/04
Filed: 1992-10-13
Granted: 1995-10-16
Abstract: A conveying device for granular and/or powdery (pulverulent) solid materials such as plastics granules 34 or the like from a storage silo 33 or the like into a supply container 9 disposed upstream of a processing station, in particular the plastications barrel of the extruder of an injection moulding machine, in which device the storage silo 33 or the like is constantly connected to the supply container 9 via a hose line and/or pipeline 29. A compact design, which is not very susceptible to malfunction in operation, of the device is achieved in that one end 30 of the hose line and/or pipeline 29 is constantly immersed by means of a lance 32 - from above - in the solid materials 34 disposed in the storage silo 33 or the like, in that the second end 31 of the hose line and/or pipeline 29 opens out into the storage container 9, and in that this second end 31 of the hose line and/or pipeline has allocated to it a gas- or air-jet pump 24 to 28 which is connected to the supply container 9 above its supply space 12 with the interconnection of a filter 19. <IMAGE>
Patent DK-0576449-T3 (DK)
Inventor: AUST NORBERT
IPC: F04D23/00
Filed: 1992-03-02
Granted: 1995-08-07
Abstract: PCT No. PCT/DE92/00167 Sec. 371 Date Sep. 20, 1993 Sec. 102(e) Date Sep. 20, 1993 PCT Filed Mar. 2, 1992 PCT Pub. No. WO92/16752 PCT Pub. Date Oct. 1, 1992.A regenerative compressor has a housing in which an impeller (6) rotates. The impeller has a supporting ring (7) fitted with blades (8) and is connected by a wall section (9) to a hub element (10) which can be placed on a drive shaft (5). The wall section (9) forms one lateral boundary wall of the impeller (6) and its axial thickness is less than the axial width of the impeller (6). The other boundary wall of the impeller is formed by an annular cover part (14) secured to the impeller. The cover part extends along at least a partial region between the supporting ring (7) and the hub element (10) and its rim is applied to a corner recess (17) of the supporting ring (7). The compressor also has rectilinear sealing gaps (13 and 23) which extend linearly along their whole length between the boundary walls of the impeller (6) and the walls (12 and 22) of the housing. To simplify the assembly of the cover part, the cover part (14) extends over the whole region between supporting ring (7) and hub element (10) and is clamped axially against the supporting ring (7) and against the hub element (10).
Patent DK-0571891-T3 (DK)
Inventor: SMITH STEVEN L
IPC: G06K7/10
Filed: 1993-05-19
Granted: 1999-07-19
Abstract: An optical object scanning system having an optical scanning device (50, 154) for providing a scan output signal including a scan output information portion representative of a scanned region of said object, comprises white reference means (154, 402) for providing a white reference signal; and adjusting means (360, 400) for adjusting the information amplitude of said scan output information portion in accordance with said white reference signal. An optical scanning method in a system including an optical scanning device (50, 154) having scan cycles with an optical scanning rate for providing a scan output signal including a scan output information component having a varying information amplitude representative of the light received by said optical scanning device, comprises the steps of providing a varying white reference signal representative of said received light, and adjusting said information amplitude of said scan output information component in accordance with said white reference signal.   <IMAGE>
Patent DK-0562853-T3 (DK)
Inventor: SEHGAL SUREN NATH
IPC: A61K31/436
Filed: 1993-03-25
Granted: 1996-07-01
Abstract: This invention relates a method of inducing immunosuppression in a mammal in need thereof which comprises, administering an anti-rejection effective amount of 29-demethoxyrapamycin alone or in combination with one or more anti-rejection chemotherapeutic agents.
Patent DK-0618900-T3 (DK)
Inventor: KOZLIK ANTONIN
IPC: A61K31/472
Filed: 1992-12-12
Granted: 1997-04-07
Abstract: PCT No. PCT/EP92/02900 Sec. 371 Date Aug. 18, 1994 Sec. 102(e) Date Aug. 18, 1994 PCT Filed Dec. 12, 1992 PCT Pub. No. WO93/13073 PCT Pub. Date Jul. 8, 1993.Tetrahydroisoquinoline compounds of formula I    <IMAGE>  I  and pharmaceutically acceptable salts and lipophilic ester thereof have utility as analgesics and in the treatment of psychoses, Parinson's disease, Lesch-Nyan syndrome, attention deficit disorder or cognitive impairment or in the relief of drug dependence or tardive dyskinesia.
Patent DK-0620709-T3 (DK)
Inventor: KIVITS MARINUS GERARDUS CORNEL
IPC: C12N9/08
Filed: 1993-01-14
Granted: 1995-12-04
Abstract: PCT No. PCT/NL93/00014 Sec. 371 Date Sep. 20, 1994 Sec. 102(e) Date Sep. 20, 1994 PCT Filed Jan. 14, 1993 PCT Pub. No. WO93/13676 PCT Pub. Date Jul. 22, 1993A process for isolating the metalloprotein lactoferrin and the enzyme lactoperoxidase from milk and milk products on an industrial scale is disclosed. The process includes the steps of adsorbing these proteins to a cation exchanger by passing milk or the milk derivatives over the cation exchanger at a high superficial velocity (more than 500 cm per hour) and at a high liquid load (100-600 bed volumes per hour); eluting these proteins, separately or simultaneously, by elution with one or more salt solutions, so as to form one or more eluates; and optionally followed by drying of the eluates.
Patent DK-0633983-T3 (DK)
Inventor: MEIJER SJOERD
IPC: B66F9/22
Filed: 1993-03-29
Granted: 1996-08-19
Abstract: PCT No. PCT/NL93/00077 Sec. 371 Date Aug. 9, 1994 Sec. 102(e) Date Aug. 9, 1994 PCT Filed Mar. 29, 1993 PCT Pub. No. WO93/20354 PCT Pub. Date Oct. 14, 1993A hydraulic device comprising at least two cylinder-piston assemblies. Each of the assemblies are of the double-action type with a front and rear chamber on either side of a piston. The chambers are connected in series in a hydraulic control circuit such that the front chamber of a first assembly has a direct connection to a rear chamber of a second assembly. At least one of the cylinder-piston assemblies is provided with a valve assembly which opens a bypass thereby bypassing the piston of the assembly when the piston is situated close to the direct connection at the end of its stroke and the effective piston surfaces are the same in the chambers mutually connected by the direct connection.
Patent DK-0655954-T3 (DK)
Inventor: AFFINITO JOHN DAVID
IPC: H01M10/05
Filed: 1993-07-30
Granted: 1999-06-07
Abstract: The present invention is the formation of solid polymer layers under vacuum. More specifically, the present invention is the use of "standard" polymer layer-making equipment that is generally used in an atmospheric environment in a vacuum, and degassing the monomer material prior to injection into the vacuum. Additional layers of polymer or metal or oxide may be vacuum deposited onto solid polymer layers. Formation of polymer layers under a vacuum improves material and surface characteristics, and subsequent quality of bonding to additional layers. Further advantages include use of less to no photoinitiator for curing, faster curing, fewer impurities in the polymer electrolyte, as well as improvement in material properties including no trapped gas resulting in greater density, and reduced monomer wetting angle that facilitates spreading of the monomer and provides a smoother finished surface.
Patent DK-0724575-T3 (DK)
Inventor: MAYER HORST
IPC: C07D251/16
Filed: 1994-10-10
Granted: 1997-10-27
Abstract: PCT No. PCT/EP94/03331 Sec. 371 Date Mar. 29, 1996 Sec. 102(e) Date Mar. 29, 1996 PCT Filed Oct. 10, 1994 PCT Pub. No. WO95/11237 PCT Pub. Date Apr. 27, 1995A process for preparing asymmetrically substituted triazines of the formula I    <IMAGE>  I  where R1 is hydrogen, methyl or ethyl, R2 and R3 independently of one another are an unsubstituted or substituted hydrocarbon radical, by reaction of a cyanoguanidine of the formula II    <IMAGE>  II  with a carboxylic acid derivative in the presence of an alcohol of the formula III R2-OHIII,which comprises reacting a carboxylic acid ester of the formula IV R3-COOR4IV,where R3 has the abovementioned meaning and R4 is an unsubstituted or substituted hydrocarbon radical, in the presence of a base or of a carboxamide selected from the group consisting of N,N-dialkylformamide, N,N-dialkylacetamide and N-methylpyrrolidone and in the presence of a salt or of a salt-like compound of the elements magnesium, calcium, aluminum, zinc, copper, iron, cobalt, nickel or chromium, is described.
Patent DK-0667223-T3 (DK)
Inventor: DANNOEHL PETER
IPC: C01B21/04
Filed: 1995-01-21
Granted: 1999-02-15
Abstract: The apparatus includes an air compressor (13), which is cooled by direct oil injection, and an air cooler (14) connected downstream of it which serves as a condensate separator. Connected to it is a heat exchanger (18) which is heated by the waste heat from the oil discharged from the air compressor (13). The temperature of the air is raised thereby to a level at which the separators (4) downstream thereof develop their optimum efficiency. The nitrogen flowing out of the separators (4), the purity of which is predetermined by a downstream throttle (3), flows into an inflatable reservoir (5) which is connected to the suction side of a high pressure compressor. The latter discharges into a high pressure storage container which for its part supplies an injection moulding machine. The nitrogen is conveyed in a closed circuit between the injection moulding machine and the inflatable reservoir. The control of the installation ensures that only as much nitrogen need be produced as is necessary to compensate for leakage losses from the circuit.
Patent DK-0677905-T3 (DK)
Inventor: STARCK THIERRY
IPC: H02B11/10
Filed: 1995-04-10
Granted: 1999-12-06
Abstract: The circuit breaker includes a housing having a panel or access door (10) enclosing the three poles of a circuit breaker, contactor or switch. These poles are mounted on a common spindle, rotating about an axis (14), to produce the circuit breaking action. The access door has a porthole (11), enabling part of a face (5A) of an inner enclosure (5), to be seen. This enclosure face has an opening (12), for viewing a mechanical indicator ((13,13A) of the open or closed state, of the switch. The indicator has segments (21') on its surface, with two complementary segments (23',23'') on the enclosure face. These segments are visible through the porthole, centred about the spindle axis. Housing segments (25',25'') may provide additional fixed indications. <IMAGE>